TFG Asset Management’s Avadel Pharmaceuticals AVDL Stock Holding History

TFG Asset Management’s Portfolio AVDL Stock Details AVDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-43,763	Closed	-$943K	–	37
2025 Q4	$943K	Buy	+43,763	New	+$850K	0.2%	28

Other funds holding AVDL

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

TFG Asset Management's AVDL Position: Q1 2026 in Review

TFG Asset Management sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 43,763 shares — an estimated $943K sold.

TFG Asset Management first reported a position in AVDL in Q4 2025 and held it in 1 quarter. The position peaked at $943K in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

TFG Asset Management reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
TFG Asset Management sold 43,763 Avadel Pharmaceuticals shares in Q1 2026, an estimated $943K.
TFG Asset Management first reported a position in Avadel Pharmaceuticals in Q4 2025 and held it in 1 quarter.
TFG Asset Management's Avadel Pharmaceuticals position peaked at $943K in Q4 2025.
2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on TFG Asset Management's 13F filing for Q1 2026, filed 15 May 2026.